nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—NOS3—Doxorubicin—testicular cancer	0.61	0.732	CbGbCtD
Tetrahydrobiopterin—PTGS2—Cisplatin—testicular cancer	0.113	0.135	CbGbCtD
Tetrahydrobiopterin—PTGS2—Etoposide—testicular cancer	0.111	0.133	CbGbCtD
Tetrahydrobiopterin—NOS3—vein—testicular cancer	0.032	0.619	CbGeAlD
Tetrahydrobiopterin—TH—embryo—testicular cancer	0.00673	0.13	CbGeAlD
Tetrahydrobiopterin—NOS3—testis—testicular cancer	0.00296	0.0573	CbGeAlD
Tetrahydrobiopterin—TH—lymph node—testicular cancer	0.00239	0.0462	CbGeAlD
Tetrahydrobiopterin—NOS3—lymph node—testicular cancer	0.00215	0.0416	CbGeAlD
Tetrahydrobiopterin—PTGS2—embryo—testicular cancer	0.00192	0.0371	CbGeAlD
Tetrahydrobiopterin—PTGS2—seminal vesicle—testicular cancer	0.0018	0.0349	CbGeAlD
Tetrahydrobiopterin—Rhinorrhoea—Cisplatin—testicular cancer	0.00169	0.0147	CcSEcCtD
Tetrahydrobiopterin—Infection—Carboplatin—testicular cancer	0.00166	0.0144	CcSEcCtD
Tetrahydrobiopterin—Respiratory failure—Ifosfamide—testicular cancer	0.00162	0.0141	CcSEcCtD
Tetrahydrobiopterin—Urine output increased—Ifosfamide—testicular cancer	0.00144	0.0125	CcSEcCtD
Tetrahydrobiopterin—Cardiovascular disorder—Etoposide—testicular cancer	0.00143	0.0124	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Chlorambucil—testicular cancer	0.00141	0.0122	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Carboplatin—testicular cancer	0.00132	0.0114	CcSEcCtD
Tetrahydrobiopterin—Polyuria—Ifosfamide—testicular cancer	0.00131	0.0114	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Vinblastine—testicular cancer	0.00122	0.0105	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Vinblastine—testicular cancer	0.00121	0.0105	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Ifosfamide—testicular cancer	0.00115	0.01	CcSEcCtD
Tetrahydrobiopterin—Polyuria—Cisplatin—testicular cancer	0.00113	0.00983	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Vinblastine—testicular cancer	0.0011	0.00953	CcSEcCtD
Tetrahydrobiopterin—Nasal congestion—Cisplatin—testicular cancer	0.00109	0.00948	CcSEcCtD
Tetrahydrobiopterin—PTGS2—female gonad—testicular cancer	0.00106	0.0205	CbGeAlD
Tetrahydrobiopterin—Acute coronary syndrome—Bleomycin—testicular cancer	0.00103	0.0089	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Bleomycin—testicular cancer	0.00102	0.00885	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Dactinomycin—testicular cancer	0.00102	0.00883	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Cisplatin—testicular cancer	0.000995	0.00863	CcSEcCtD
Tetrahydrobiopterin—Agitation—Chlorambucil—testicular cancer	0.000966	0.00838	CcSEcCtD
Tetrahydrobiopterin—Irritability—Cisplatin—testicular cancer	0.00095	0.00824	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Chlorambucil—testicular cancer	0.000911	0.0079	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Cisplatin—testicular cancer	0.00089	0.00772	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Ifosfamide—testicular cancer	0.00089	0.00772	CcSEcCtD
Tetrahydrobiopterin—Infestation—Ifosfamide—testicular cancer	0.00089	0.00772	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Ifosfamide—testicular cancer	0.000877	0.00761	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Ifosfamide—testicular cancer	0.000872	0.00757	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Dactinomycin—testicular cancer	0.000865	0.0075	CcSEcCtD
Tetrahydrobiopterin—Infection—Chlorambucil—testicular cancer	0.000852	0.00739	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Vinblastine—testicular cancer	0.000835	0.00724	CcSEcCtD
Tetrahydrobiopterin—Cardiovascular disorder—Epirubicin—testicular cancer	0.000801	0.00695	CcSEcCtD
Tetrahydrobiopterin—Respiratory failure—Methotrexate—testicular cancer	0.000766	0.00665	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Cisplatin—testicular cancer	0.000756	0.00656	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Chlorambucil—testicular cancer	0.000755	0.00655	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Cisplatin—testicular cancer	0.000752	0.00652	CcSEcCtD
Tetrahydrobiopterin—Cardiovascular disorder—Doxorubicin—testicular cancer	0.000741	0.00643	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.000741	0.00643	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Etoposide—testicular cancer	0.000737	0.00639	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Ifosfamide—testicular cancer	0.00072	0.00624	CcSEcCtD
Tetrahydrobiopterin—Cough—Bleomycin—testicular cancer	0.00071	0.00616	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Etoposide—testicular cancer	0.000703	0.0061	CcSEcCtD
Tetrahydrobiopterin—Infestation—Etoposide—testicular cancer	0.000703	0.0061	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Chlorambucil—testicular cancer	0.000701	0.00609	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Ifosfamide—testicular cancer	0.000695	0.00603	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Etoposide—testicular cancer	0.000693	0.00601	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Etoposide—testicular cancer	0.000689	0.00598	CcSEcCtD
Tetrahydrobiopterin—PTGS2—lymph node—testicular cancer	0.00068	0.0132	CbGeAlD
Tetrahydrobiopterin—Urine output increased—Methotrexate—testicular cancer	0.00068	0.0059	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Chlorambucil—testicular cancer	0.000678	0.00588	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Chlorambucil—testicular cancer	0.000678	0.00588	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Bleomycin—testicular cancer	0.000664	0.00576	CcSEcCtD
Tetrahydrobiopterin—Infection—Bleomycin—testicular cancer	0.00066	0.00572	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Vinblastine—testicular cancer	0.000643	0.00558	CcSEcCtD
Tetrahydrobiopterin—Agitation—Ifosfamide—testicular cancer	0.000639	0.00554	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Chlorambucil—testicular cancer	0.000632	0.00548	CcSEcCtD
Tetrahydrobiopterin—Polyuria—Methotrexate—testicular cancer	0.000622	0.0054	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Vinblastine—testicular cancer	0.000621	0.00539	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Cisplatin—testicular cancer	0.000621	0.00538	CcSEcCtD
Tetrahydrobiopterin—Infection—Dactinomycin—testicular cancer	0.000615	0.00534	CcSEcCtD
Tetrahydrobiopterin—Cough—Ifosfamide—testicular cancer	0.000607	0.00526	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000605	0.00525	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Ifosfamide—testicular cancer	0.000602	0.00523	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Cisplatin—testicular cancer	0.000599	0.0052	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Ifosfamide—testicular cancer	0.000592	0.00514	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.000588	0.0051	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Chlorambucil—testicular cancer	0.000587	0.00509	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Vinblastine—testicular cancer	0.000579	0.00502	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Etoposide—testicular cancer	0.000568	0.00493	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Ifosfamide—testicular cancer	0.000567	0.00492	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000564	0.00489	CcSEcCtD
Tetrahydrobiopterin—Infection—Ifosfamide—testicular cancer	0.000564	0.00489	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Ifosfamide—testicular cancer	0.000556	0.00483	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Ifosfamide—testicular cancer	0.000551	0.00478	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Chlorambucil—testicular cancer	0.000545	0.00473	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Vinblastine—testicular cancer	0.000538	0.00467	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Bleomycin—testicular cancer	0.000525	0.00455	CcSEcCtD
Tetrahydrobiopterin—Irritability—Methotrexate—testicular cancer	0.000521	0.00452	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Vinblastine—testicular cancer	0.00052	0.00451	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Cisplatin—testicular cancer	0.000519	0.00451	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000517	0.00448	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.000511	0.00443	CcSEcCtD
Tetrahydrobiopterin—Nausea—Chlorambucil—testicular cancer	0.00051	0.00442	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000507	0.0044	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000506	0.00439	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Vinblastine—testicular cancer	0.0005	0.00434	CcSEcCtD
Tetrahydrobiopterin—Headache—Vinblastine—testicular cancer	0.000492	0.00427	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00049	0.00425	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Dactinomycin—testicular cancer	0.000489	0.00425	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Dactinomycin—testicular cancer	0.000489	0.00425	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Cisplatin—testicular cancer	0.000489	0.00424	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Bleomycin—testicular cancer	0.000489	0.00424	CcSEcCtD
Tetrahydrobiopterin—Infection—Cisplatin—testicular cancer	0.000486	0.00422	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Cisplatin—testicular cancer	0.00048	0.00416	CcSEcCtD
Tetrahydrobiopterin—Cough—Etoposide—testicular cancer	0.000479	0.00416	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Etoposide—testicular cancer	0.000476	0.00413	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Cisplatin—testicular cancer	0.000475	0.00412	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.000473	0.0041	CcSEcCtD
Tetrahydrobiopterin—Nausea—Vinblastine—testicular cancer	0.000467	0.00405	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Epirubicin—testicular cancer	0.000467	0.00405	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000464	0.00403	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000464	0.00403	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Epirubicin—testicular cancer	0.000457	0.00397	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Dactinomycin—testicular cancer	0.000456	0.00396	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Epirubicin—testicular cancer	0.000452	0.00392	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Ifosfamide—testicular cancer	0.000449	0.00389	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Ifosfamide—testicular cancer	0.000449	0.00389	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Etoposide—testicular cancer	0.000448	0.00389	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000446	0.00387	CcSEcCtD
Tetrahydrobiopterin—Infection—Etoposide—testicular cancer	0.000445	0.00386	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Methotrexate—testicular cancer	0.000441	0.00383	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000439	0.00381	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Etoposide—testicular cancer	0.000435	0.00378	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Doxorubicin—testicular cancer	0.000432	0.00375	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Dactinomycin—testicular cancer	0.000424	0.00368	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Doxorubicin—testicular cancer	0.000423	0.00367	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000422	0.00366	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Bleomycin—testicular cancer	0.000422	0.00366	CcSEcCtD
Tetrahydrobiopterin—Infestation—Methotrexate—testicular cancer	0.000421	0.00365	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Methotrexate—testicular cancer	0.000421	0.00365	CcSEcCtD
Tetrahydrobiopterin—Rash—Bleomycin—testicular cancer	0.000419	0.00363	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Doxorubicin—testicular cancer	0.000419	0.00363	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Bleomycin—testicular cancer	0.000418	0.00363	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Ifosfamide—testicular cancer	0.000418	0.00363	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Epirubicin—testicular cancer	0.000413	0.00358	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000411	0.00356	CcSEcCtD
Tetrahydrobiopterin—Nausea—Bleomycin—testicular cancer	0.000394	0.00342	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Epirubicin—testicular cancer	0.000394	0.00342	CcSEcCtD
Tetrahydrobiopterin—Infestation—Epirubicin—testicular cancer	0.000394	0.00342	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Dactinomycin—testicular cancer	0.000394	0.00342	CcSEcCtD
Tetrahydrobiopterin—Rash—Dactinomycin—testicular cancer	0.00039	0.00339	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Ifosfamide—testicular cancer	0.000388	0.00337	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Etoposide—testicular cancer	0.000387	0.00336	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Cisplatin—testicular cancer	0.000387	0.00335	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Epirubicin—testicular cancer	0.000383	0.00332	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Doxorubicin—testicular cancer	0.000382	0.00332	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00038	0.0033	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Ifosfamide—testicular cancer	0.000375	0.00326	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Methotrexate—testicular cancer	0.000375	0.00325	CcSEcCtD
Tetrahydrobiopterin—Nausea—Dactinomycin—testicular cancer	0.000368	0.00319	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Etoposide—testicular cancer	0.000366	0.00318	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Doxorubicin—testicular cancer	0.000364	0.00316	CcSEcCtD
Tetrahydrobiopterin—Infestation—Doxorubicin—testicular cancer	0.000364	0.00316	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Ifosfamide—testicular cancer	0.000361	0.00313	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Cisplatin—testicular cancer	0.00036	0.00313	CcSEcCtD
Tetrahydrobiopterin—Rash—Ifosfamide—testicular cancer	0.000358	0.0031	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Ifosfamide—testicular cancer	0.000357	0.0031	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Etoposide—testicular cancer	0.000354	0.00307	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Etoposide—testicular cancer	0.000354	0.00307	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Doxorubicin—testicular cancer	0.000354	0.00307	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Epirubicin—testicular cancer	0.000351	0.00304	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Epirubicin—testicular cancer	0.000348	0.00302	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Methotrexate—testicular cancer	0.000341	0.00295	CcSEcCtD
Tetrahydrobiopterin—Nausea—Ifosfamide—testicular cancer	0.000337	0.00292	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Cisplatin—testicular cancer	0.000335	0.0029	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Etoposide—testicular cancer	0.00033	0.00286	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Methotrexate—testicular cancer	0.000329	0.00285	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Doxorubicin—testicular cancer	0.000325	0.00282	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Doxorubicin—testicular cancer	0.000322	0.0028	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Epirubicin—testicular cancer	0.000319	0.00276	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Cisplatin—testicular cancer	0.000311	0.0027	CcSEcCtD
Tetrahydrobiopterin—Rash—Cisplatin—testicular cancer	0.000308	0.00268	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Cisplatin—testicular cancer	0.000308	0.00267	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Epirubicin—testicular cancer	0.000308	0.00267	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Etoposide—testicular cancer	0.000307	0.00266	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Etoposide—testicular cancer	0.000296	0.00257	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Doxorubicin—testicular cancer	0.000295	0.00256	CcSEcCtD
Tetrahydrobiopterin—Nausea—Cisplatin—testicular cancer	0.000291	0.00252	CcSEcCtD
Tetrahydrobiopterin—Cough—Methotrexate—testicular cancer	0.000287	0.00249	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Methotrexate—testicular cancer	0.000285	0.00247	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Etoposide—testicular cancer	0.000285	0.00247	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Doxorubicin—testicular cancer	0.000285	0.00247	CcSEcCtD
Tetrahydrobiopterin—Agitation—Epirubicin—testicular cancer	0.000283	0.00245	CcSEcCtD
Tetrahydrobiopterin—Rash—Etoposide—testicular cancer	0.000283	0.00245	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Etoposide—testicular cancer	0.000282	0.00245	CcSEcCtD
Tetrahydrobiopterin—Headache—Etoposide—testicular cancer	0.000281	0.00244	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Methotrexate—testicular cancer	0.00028	0.00243	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000278	0.00241	CcSEcCtD
Tetrahydrobiopterin—Cough—Epirubicin—testicular cancer	0.000269	0.00233	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Methotrexate—testicular cancer	0.000268	0.00233	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Epirubicin—testicular cancer	0.000267	0.00231	CcSEcCtD
Tetrahydrobiopterin—Infection—Methotrexate—testicular cancer	0.000267	0.00231	CcSEcCtD
Tetrahydrobiopterin—Nausea—Etoposide—testicular cancer	0.000266	0.00231	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Methotrexate—testicular cancer	0.000263	0.00228	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Epirubicin—testicular cancer	0.000262	0.00227	CcSEcCtD
Tetrahydrobiopterin—Agitation—Doxorubicin—testicular cancer	0.000262	0.00227	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Methotrexate—testicular cancer	0.000261	0.00226	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00026	0.00226	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Epirubicin—testicular cancer	0.000251	0.00218	CcSEcCtD
Tetrahydrobiopterin—Infection—Epirubicin—testicular cancer	0.00025	0.00217	CcSEcCtD
Tetrahydrobiopterin—Cough—Doxorubicin—testicular cancer	0.000249	0.00216	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Doxorubicin—testicular cancer	0.000247	0.00214	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Epirubicin—testicular cancer	0.000246	0.00214	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000245	0.00212	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Epirubicin—testicular cancer	0.000244	0.00212	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Doxorubicin—testicular cancer	0.000242	0.0021	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000241	0.00209	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Methotrexate—testicular cancer	0.000236	0.00205	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000232	0.00202	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000232	0.00201	CcSEcCtD
Tetrahydrobiopterin—Infection—Doxorubicin—testicular cancer	0.000231	0.002	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000229	0.00199	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Doxorubicin—testicular cancer	0.000228	0.00198	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Doxorubicin—testicular cancer	0.000226	0.00196	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Epirubicin—testicular cancer	0.000221	0.00192	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Methotrexate—testicular cancer	0.00022	0.0019	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000217	0.00188	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Methotrexate—testicular cancer	0.000212	0.00184	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Methotrexate—testicular cancer	0.000212	0.00184	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000212	0.00184	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000205	0.00178	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Doxorubicin—testicular cancer	0.000205	0.00178	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000201	0.00174	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Epirubicin—testicular cancer	0.000199	0.00172	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Epirubicin—testicular cancer	0.000199	0.00172	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Methotrexate—testicular cancer	0.000198	0.00172	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00019	0.00165	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Epirubicin—testicular cancer	0.000185	0.00161	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Doxorubicin—testicular cancer	0.000184	0.00159	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Doxorubicin—testicular cancer	0.000184	0.00159	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Methotrexate—testicular cancer	0.000184	0.00159	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Methotrexate—testicular cancer	0.000178	0.00154	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Epirubicin—testicular cancer	0.000172	0.00149	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Doxorubicin—testicular cancer	0.000171	0.00149	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Methotrexate—testicular cancer	0.000171	0.00148	CcSEcCtD
Tetrahydrobiopterin—Rash—Methotrexate—testicular cancer	0.000169	0.00147	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Methotrexate—testicular cancer	0.000169	0.00147	CcSEcCtD
Tetrahydrobiopterin—Headache—Methotrexate—testicular cancer	0.000168	0.00146	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Epirubicin—testicular cancer	0.000166	0.00144	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Epirubicin—testicular cancer	0.00016	0.00139	CcSEcCtD
Tetrahydrobiopterin—Nausea—Methotrexate—testicular cancer	0.000159	0.00138	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Doxorubicin—testicular cancer	0.000159	0.00138	CcSEcCtD
Tetrahydrobiopterin—Rash—Epirubicin—testicular cancer	0.000158	0.00137	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Epirubicin—testicular cancer	0.000158	0.00137	CcSEcCtD
Tetrahydrobiopterin—Headache—Epirubicin—testicular cancer	0.000157	0.00137	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Doxorubicin—testicular cancer	0.000154	0.00133	CcSEcCtD
Tetrahydrobiopterin—Nausea—Epirubicin—testicular cancer	0.000149	0.00129	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Doxorubicin—testicular cancer	0.000148	0.00128	CcSEcCtD
Tetrahydrobiopterin—Rash—Doxorubicin—testicular cancer	0.000147	0.00127	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Doxorubicin—testicular cancer	0.000146	0.00127	CcSEcCtD
Tetrahydrobiopterin—Headache—Doxorubicin—testicular cancer	0.000146	0.00126	CcSEcCtD
Tetrahydrobiopterin—Nausea—Doxorubicin—testicular cancer	0.000138	0.0012	CcSEcCtD
